Clinical trial
A Study of the Safety and Effectiveness of Infliximab in Patients With…
NCT00106847 · Centocor, Inc., Industry · Completed
Key facts
| NCT number | NCT00106847 |
|---|---|
| Title | A Study of the Safety and Effectiveness of Infliximab in Patients With Plaque-type Psoriasis |
| Official title | A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Infliximab Induction Therapy Followed by Multiple Regimens of Maintenance InfliximabTherapy in Patients With Plaque-Type Psoriasis |
| Lead sponsor | Centocor, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Psoriasis, Parapsoriasis |
| Intervention type | Drug |
| Interventions | Infliximab |
| Enrollment | 683 |
| Start date | Jan 1, 2003 |
| Completion | Jul 1, 2005 |
| First posted | Apr 1, 2005 |
| Last update posted | May 17, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: